AH077 - Rx Retro: An Approach to Safe & Effective Deprescribing, with Lauren Carroll, PharmD
Description
In this episode of the Astonishing Healthcare podcast, host Justin Venneri sits down with Lauren Carroll, PharmD, a Senior Clinical Programs Manager at Capital Rx, to discuss Rx Retro, a pharmacist-led program that focuses on medication deprescribing to enhance patient safety, reduce adverse drug events, and improve healthcare outcomes. Lauren shares insights into how Rx Retro leverages Judi® - Capital Rx's enterprise health platform - to identify and address drug therapy concerns through a series of alerts and outreach designed to promote the safest and most effective treatments for plan members. The conversation also highlights the broader implications of deprescribing for healthcare quality and cost savings, with Lauren noting that, "We are uniquely positioned to bridge gaps that exist in the healthcare system."
Highlights
- Deprescribing Defined: The process of discontinuing potentially inappropriate medications under a healthcare provider's supervision.
- Judi® identifies drug therapy concerns in real-time, even across multiple prescribers and pharmacies.
- Rx Retro's Two Levels: Level 1 involves fax notifications to prescribers, while Level 2 includes direct pharmacist outreach and patient counseling.
- Broader Impact: Rx Retro addresses clinical areas like polypharmacy, duplication of therapy, and high-risk medications in vulnerable populations, and can help with quality metrics and scores that impact plans' star ratings.
Related Content:
- AH035 - Pharmacy Benefits 101: Clinical Programs, with Bonnie Hui-Callahan, PharmD
- Pharmacy Benefits 101: Building an Award-Winning Call Center from Scratch
- AH006 - Pharmacy Benefits 101: Clinical Care Teams, with Amy Stockton, PharmD
- Pharmacy Benefits 101: What’s the Drug Management Program (DMP)?
- AH073 - How Low Cost Alternative Programs Can & Should Work, with Jackie Lolos, PharmD, and Haleh Campbell, PharmD
For more information about Capital Rx and this episode, please visit Capital Rx Insights.